CN Patent

CN103889455B — 稳定化乙哌立松医药组成物及含有上述组成物的缓释制剂

Assigned to Navipharm Co Ltd · Expires 2017-12-05 · 8y expired

What this patent protects

本发明涉及稳定化乙哌立松医药组成物及含有上述组成物的缓释制剂。具体是，由活性成分乙哌立松盐和酸化剂组成，成品存放期间乃至药物在患者体内滞留期间，皆可保持活性成分化学稳定性的稳定化乙哌立松医药组成物，以及除了该乙哌立松和酸化剂以外还包含延迟释放剂，以发挥速效性和持效性双重释放特性的含稳定化乙哌立松的释放制剂。

USPTO Abstract

本发明涉及稳定化乙哌立松医药组成物及含有上述组成物的缓释制剂。具体是，由活性成分乙哌立松盐和酸化剂组成，成品存放期间乃至药物在患者体内滞留期间，皆可保持活性成分化学稳定性的稳定化乙哌立松医药组成物，以及除了该乙哌立松和酸化剂以外还包含延迟释放剂，以发挥速效性和持效性双重释放特性的含稳定化乙哌立松的释放制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN103889455B
Jurisdiction
CN
Classification
—
Expires
2017-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Navipharm Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.